Ignite Creation Date:
2024-05-05 @ 11:43 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00116727
Status:
COMPLETED
Last Update Posted:
2011-05-06
First Post:
2005-06-30
Brief Title:
Rheumatoid Arthritis DMARD Intervention and UtilizationStudy
Sponsor:
Amgen
Organization:
Amgen
Study Overview
Official Title:
Rheumatoid Arthritis Disease Modifying Anti-Rheumatic Drug DMARD Intervention and Utilization Study RADIUS 2
Status:
COMPLETED
Status Verified Date:
2011-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To systematically collect and document use patterns effectiveness and safety of DMARD treatments currently used in the management of rheumatoid arthritis The primary purpose of this study is to estimate the incidence of serious adverse experiences and adverse experiences of interest in patients with rheumatoid arthritis RA treated with ENBREL
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 0160035 | None | None | None |